Susquehanna International Group
CBPO

Susquehanna International Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Susquehanna International Group’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-26,400
Closed -$2.93M – 12158
2020
Q3 		$2.93M Sell
26,400
-4,200
-14% -$451K ﹤0.01% 3893
2020
Q2 		$3.13M Sell
30,600
-1,200
-4% -$128K ﹤0.01% 3734
2020
Q1 		$3.43M Sell
31,800
-6,300
-17% -$724K ﹤0.01% 3090
2019
Q4 		$4.43M Buy
38,100
+20,100
+112% +$2.33M ﹤0.01% 3142
2019
Q3 		$2.06M Buy
18,000
+10,100
+128% +$1M ﹤0.01% 4125
2019
Q2 		$753K Sell
7,900
-43,800
-85% -$4.13M ﹤0.01% 6335
2019
Q1 		$4.72M Buy
51,700
+6,600
+15% +$540K ﹤0.01% 2523
2018
Q4 		$3.42M Sell
45,100
-20,300
-31% -$1.49M ﹤0.01% 2743
2018
Q3 		$5.23M Buy
65,400
+19,900
+44% +$1.85M ﹤0.01% 2641
2018
Q2 		$4.52M Buy
45,500
+15,600
+52% +$1.35M ﹤0.01% 2841
2018
Q1 		$2.42M Buy
29,900
+25,000
+510% +$2.02M ﹤0.01% 3570
2017
Q4 		$386K Sell
4,900
-23,400
-83% -$1.95M ﹤0.01% 7129
2017
Q3 		$2.61M Sell
28,300
-3,500
-11% -$336K ﹤0.01% 3443
2017
Q2 		$3.6M Sell
31,800
-39,800
-56% -$4.45M ﹤0.01% 2862
2017
Q1 		$7.17M Buy
71,600
+62,600
+696% +$6.69M ﹤0.01% 1969
2016
Q4 		$968K Sell
9,000
-33,900
-79% -$3.96M ﹤0.01% 5601
2016
Q3 		$5.34M Buy
42,900
+19,100
+80% +$2.25M ﹤0.01% 2160
2016
Q2 		$2.53M Sell
23,800
-52,000
-69% -$6.04M ﹤0.01% 3181
2016
Q1 		$8.68M Buy
75,800
+58,300
+333% +$6.84M ﹤0.01% 1696
2015
Q4 		$2.49M Sell
17,500
-49,300
-74% -$5.69M ﹤0.01% 3623
2015
Q3 		$6M Buy
66,800
+29,800
+81% +$3.15M ﹤0.01% 2424
2015
Q2 		$4.26M Buy
37,000
+29,600
+400% +$3.11M ﹤0.01% 3173
2015
Q1 		$707K Sell
7,400
-4,600
-38% -$344K ﹤0.01% 6455
2014
Q4 		$807K Buy
12,000
+5,200
+76% +$322K ﹤0.01% 6287
2014
Q3 		$367K Buy
+6,800
New +$335K ﹤0.01% 7728
2014
Q2 		– Sell
-6,100
Closed -$212K – 10336
2014
Q1 		$212K Buy
+6,100
New +$194K ﹤0.01% 8148

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.38% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Susquehanna International Group's CBPO Position: Q1 2021 in Review

Susquehanna International Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2021, closing a stake of 4,984 shares — an estimated $589K sold.

Susquehanna International Group first reported a position in CBPO in Q2 2014 and held it in 23 quarters. The position peaked at $32.6M in Q3 2019. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.

  • Susquehanna International Group reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
  • Susquehanna International Group sold 4,984 China Biologic Products Holdings, Inc. shares in Q1 2021, an estimated $589K.
  • Susquehanna International Group first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 23 quarters.
  • Susquehanna International Group's China Biologic Products Holdings, Inc. position peaked at $32.6M in Q3 2019.
  • 86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.

Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.